Megan Curtis: Raising Awareness of Pernicious Anaemia
Megan Curtis, Governance Training, Advice and Intervention Officer at Bradford Council, Clerk to the Governors at Lady Lumleys Educational Foundation, shared The Pernicious Anaemia Society‘s post on LinkedIn, adding:
“Reposting to raise awareness.
Did you know pernicious means deadly?
It was indeed this, until B12 treatment was identified less than 80 years ago.
Still often overlooked and undiagnosed – many struggle for years before a diagnosis.
PA isn’t just low iron it is an autoimmune disease which has a massive impact on those affected and requires lifelong management.”
The Pernicious Anaemia Society shared a post on LinkedIn:
“2th October is PA Day.
A day dedicated to raising awareness of Pernicious Anaemia – a lifelong autoimmune condition that is still too often missed, misdiagnosed, and misunderstood.
This year, PA Day feels particularly significant.
In September, PAS joined the B12 Alliance at a Reception at the House of Commons – taking our 20 years of patient evidence, research, and advocacy directly to the people who shape health policy in the UK.
20 years of listening to patients.
20 years of funding research.
20 years of educating healthcare professionals.
20 years of standing our ground on what Pernicious Anaemia actually is – an autoimmune condition, not simply a B12 deficiency – and what that means for how it must be diagnosed and treated.
Awareness matters because it changes things.
It changes what patients know to ask for.
It changes what healthcare professionals think to test for.
And it changes what policymakers believe is worth acting on.
On 12th October, help us continue to make some noise.
Share this post.
Tell someone what PA is.
Point someone to our website who might need it.
Every conversation started on PA Day is part of how the dial moves.
Join PAS and be part of the change.
20 years of education, research and support.
This year things change.”
Stay updated with Hemostasis Today.
-
Oct 7, 2026, 10:42Nasir K.: The Global Healthcare Community Comes Together for IPAW 2026
-
Oct 7, 2026, 09:20Maurizio Bertaina: Optimizing Anticoagulation in Temporary Mechanical Circulatory Support
-
Oct 7, 2026, 08:55Ifeanyichukwu Ifechidere: Cancer, Clotting and Bleeding – The Critical Role of Haemostasis in Oncology
-
Oct 7, 2026, 08:39Pediatric Hematology – Careers in Thrombosis and Blood Disorders – ASH Education
-
Oct 7, 2026, 07:57Edward Lee Carter: When Should Apixaban Become the Default for Acute VTE?
-
Oct 7, 2026, 07:40Annette Bowyer: Exploring New Developments in Thrombin Generation
-
Oct 7, 2026, 07:06Omid Seidizadeh: When Acquired von Willebrand Syndrome Takes Different Paths
-
Oct 7, 2026, 06:49Neeraj Songara: Can a Negative Antibody Screen Be Misleading?
-
Oct 7, 2026, 04:09James P. Crowley: Could the Microbiome Protect Us From Severe EBV Infection?